Product description

Prevail Equine Paste is a potent, nonnarcotic, nonsteroidal, analgesic agent with anti-inflammatory and antipyretic activity for oral use in horses only.

Active ingredients

Each Prevail Equine Paste syringe contains:

• Flunixin meglumine equivalent to 1500 mg flunixin

Indications for use

Prevail Equine Paste is indicated for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.

Administration and dosage

• Prevail Equine Paste recommended dose of flunixin meglumine is 0.5 mg per lb of body weight once daily.

• The Prevail Equine Paste syringe, calibrated in twelve 250-lb weight increments, delivers 125 mg of flunixin for each 250 lbs. One syringe will treat a 1000-lb horse once daily for 3 days, or three 1000-lb horses one time.

• The paste is orally administered by inserting the nozzle of the syringe through the interdental space, and depositing the required amount of paste on the back of the tongue by depressing the plunger.

• Treatment may be given initially by intravenous or intramuscular injection of Prevail Injectable Solution, followed by Prevail Equine Paste on Days 2 to 5. Flunixin meglumine treatment should not exceed 5 consecutive days.

Prescribing information